ABBV.N,UPDATE 2-AbbVie oral hep C drugs cure 96 pct in late stage trial Dec 10 AbbVie Inc's all-oral hepatitis C therapy cured 96 percent of difficult-to-treat patients in a late-stage clinical trial after 12 weeks, keeping the company well placed in a highly competitive race to deliver new treatments for the serious liver disease. ~AbbVie says 96 pct patients in oral hepatitis C study show improvement Dec 10 AbbVie Inc said a late-stage trial of its experimental hepatitis C therapy showed 96 percent of the patients who had previously failed to respond to treatment had no detectable levels of the virus in the blood after 12 weeks. ~
AZO,UPDATE 3-AutoZone to focus on sales to repair chains as retail drags * Shares rise as much as 6 pct   (Adds CEO comment, details; updates shares) ~AutoZone profit rises 7 pct due to higher repairs Dec 10 AutoZone Inc, the largest U.S. auto parts retailer, reported a 7 percent rise in quarterly profit due to higher repairs. ~
HRB,UPDATE 1-H&R; Block's loss widens as global tax filing fees fall * Q2 adjusted loss/share from continuing ops bigger than expected ~H&R; Block's loss widens as global tax preparation fees fall Dec 10 U.S. tax preparer H&R; Block Inc  reported a bigger second-quarter loss ahead of the tax filing season due to a fall in international tax preparation fees. ~BRIEF-H and R Block shares down 3.1 pct after the bell following results NEW YORK, Dec 10 H & R Block Inc :  * Shares were down 3.1 percent after the bell following results ~
BA,Washington state congressional delegates pitch for  Boeing plant WASHINGTON, D.C., Dec 10 Washington's full congressional delegation pleaded with Boeing Co on Tuesday to keep its next-generation jetliner in the state as rival states made their own pitches to lure the 777X in a contest worth billions of dollars. ~Boeing sees export credits waning as aircraft funding source LONDON More commercial jet buyers will tap rapidly-expanding capital markets to finance $112 billion of jet sales in 2014 as state-backed export credits become pricier and more politically sensitive, Boeing Co  said on Tuesday. ~UPDATE 1-Boeing sees export credits waning as aircraft funding source LONDON, Dec 10 More commercial jet buyers will tap rapidly-expanding capital markets to finance $112 billion of jet sales in 2014 as state-backed export credits become pricier and more politically sensitive, Boeing Co said on Tuesday. ~Boeing sees aircraft finance market rising to $112 billion in 2014 LONDON Commercial jet buyers are set to turn to rapidly-expanding capital markets for more financing in 2014, as the value of jet sales rises by about 7.7 percent to $112 billion, Boeing Co  forecast on Tuesday. ~Boeing sees aircraft finance market rising to $112 bln in 2014 LONDON, Dec 10 Commercial jet buyers are set to turn to rapidly-expanding capital markets for more financing in 2014, as the value of jet sales rises by about 7.7 percent to $112 billion, Boeing Co forecast on Tuesday. ~Poland's LOT agrees compensation with Boeing over Dreamliners WARSAW Polish flagship carrier LOT  said it had agreed with U.S. plane maker Boeing  on compensation for the faults that grounded its 787 Dreamliner jets. ~UPDATE 1-Poland's LOT agrees compensation with Boeing over Dreamliners * LOT has estimated cost of Dreamliner problems at $32 mln ~Poland agrees compensation with Boeing over Dreamliners-minister WARSAW, Dec 10 Polish flagship carrier LOT  has agreed with U.S. plane maker Boeing on compensation for the faults that grounded its 787 Dreamliner jets, Treasury Minister Wlodzimierz Karpinski was quoted as saying by local media on Tuesday. ~Boeing must decide on F/A-18 production in March 2014: executive NAVAL AIR STATION PATUXENT RIVER, Maryland Boeing Co  must decide in March 2014 whether to invest tens of millions of dollars to continue production of the F/A-18 fighter jet, a senior Boeing executive said on Monday, underscoring his confidence that sufficient orders would emerge to keep the plane in production until beyond 2020. ~
BMY,UPDATE 1-FDA staff cautious on AstraZeneca, Bristol diabetes drug LONDON, Dec 10 U.S. Food and Drug Administration staff said on Tuesday they were wary about the benefits versus the risks of AstraZeneca and Bristol-Myers Squibb's  new diabetes drug dapagliflozin. ~
CAH,CVS, Cardinal Health form U.S. generic drug venture Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market. ~UPDATE 2-CVS, Cardinal Health form U.S. generic drug venture Dec 10 Pharmacy chain CVS Caremark Corp  and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market. ~BRIEF-Cardinal Health shares up 3.5 pct, CVS Caremark up 1.6 pct on JV announcement NEW YORK, Dec 10 Cardinal Health Inc :  * Shares up 3.5 percent, CVS Caremark up 1.6 percent on jv announcement ~CVS, Cardinal Health enter U.S. generic drug joint venture Dec 10 Pharmacy chain CVS Caremark Corp  and pharmaceutical distributor Cardinal Health Inc said on Tuesday they would form the largest U.S. generic drug sourcing operation in a 10-year agreement to serve the world's biggest market for generic drugs. ~
C,Citigroup CFO sees Q4 markets results slipping Dec 10 Fourth-quarter capital markets and underwriting revenues this quarter are running slightly below results from a year ago, Citigroup Inc Chief Financial Officer John Gerspach said on Tuesday. ~
COH,UPDATE 1-Fifth & Pacific to sell Lucky Brand Jeans for $225 mln * Says remaining amount to be paid in the form of a 3-year seller note ~
CMCSA.O,CORRECTED-UPDATE 1-Time Warner Cable, Charter execs see benefits of deals but in no rush (Corrects attribution of quote in paragraph three to Marcus, not Rutledge) ~
CVS,CVS, Cardinal Health form U.S. generic drug venture Pharmacy chain CVS Caremark Corp and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market. ~UPDATE 2-CVS, Cardinal Health form U.S. generic drug venture Dec 10 Pharmacy chain CVS Caremark Corp  and pharmaceutical distributor Cardinal Health Inc on Tuesday announced a 10-year agreement to form the largest generic drug sourcing operation in the United States, the world's biggest generic drug market. ~BRIEF-Cardinal Health shares up 3.5 pct, CVS Caremark up 1.6 pct on JV announcement NEW YORK, Dec 10 Cardinal Health Inc :  * Shares up 3.5 percent, CVS Caremark up 1.6 percent on jv announcement ~CVS, Cardinal Health enter U.S. generic drug joint venture Dec 10 Pharmacy chain CVS Caremark Corp  and pharmaceutical distributor Cardinal Health Inc said on Tuesday they would form the largest U.S. generic drug sourcing operation in a 10-year agreement to serve the world's biggest market for generic drugs. ~
DISCA.O,Discovery considering bid for Scripps Networks-report Dec 10 Shares of Scripps Networks Interactive  soared more than 11 percent after the market closed on Tuesday on a news report that Discovery Communications  is considering a bid for the sought-after cable company. ~
DISCK.O,Discovery considering bid for Scripps Networks-report Dec 10 Shares of Scripps Networks Interactive  soared more than 11 percent after the market closed on Tuesday on a news report that Discovery Communications  is considering a bid for the sought-after cable company. ~
ETR,TIMELINE-Entergy transition to MISO caps years of wrangling HOUSTON, Dec 10 New Orleans-based Entergy Corp  is scheduled to turn over day-to-day control of its 15,000-mile (24,000-km), four-state transmission network later this month when it joins the Midcontinent Independent System Operator (MISO). ~Entergy's rocky road to MISO may revive Gulf Coast power trading HOUSTON, Dec 10 The U.S. Gulf Coast region may see a rebirth in power trading as Entergy Corp and utilities in four states join the Midcontinent Independent System Operator (MISO), one of the world's largest grid operators and wholesale energy markets, later this month. ~UPDATE 1-Mississippi rejects Entergy grid transfer to ITC HOUSTON, Dec 10 The Mississippi Public Service Commission on Tuesday rejected  Entergy Corp's deal to divest its transmission operation to ITC Holdings in a transaction valued at $1.78 billion. ~Mississippi rejects Entergy grid transfer to ITC Holdings HOUSTON, Dec 10 The Mississippi Public Service Commission on Tuesday voted to deny Entergy Corp's deal to divest its transmission operation to ITC Holdings in a transaction valued at $1.78 billion. ~
GE,UPDATE 1-GE unit to reimburse consumers misled over credit cards WASHINGTON, Dec 10 The U.S. consumer financial watchdog on Tuesday ordered a General Electric Co unit to refund up to $34.1 million to customers who it said were misled about healthcare credit cards. ~GE unit to refund customers $34 million over deceptive practices WASHINGTON, Dec 10 The U.S. consumer bureau on Tuesday ordered General Electric Co's GE Capital Retail Bank and one of its subsidiaries to refund up to $34.1 million to customers who it said were  misled about healthcare credit cards. ~
GM,GM's new president Ammann out to prove he is not a 'bean counter' DETROIT, Dec 10 General Motor Co's  incoming president has gone to great lengths to prove that while he is the U.S. automaker's chief financial officer, he is not just a "bean counter." ~GM shakes up auto industry men's club, naming first woman CEO DETROIT General Motors Co CEO Dan Akerson will step down next month and be replaced by GM "lifer" and global product chief Mary Barra, a sign that the development of new vehicles will be the paramount focus of the company that emerged from bankruptcy four years ago. |Â Video  ~UPDATE 4-GM shakes up auto industry men's club, naming first woman CEO * Akerson accelerates exit after wife's cancer diagnosis     * CFO Ammann named president, ex-Cummins CEO named chairman     * Barra will be GM's fifth CEO in less than five years     * Barra's task is to complete turnaround begun under Akerson       By Ben Klayman     DETROIT, Dec 10 General Motors Co CEO Dan Akerson will step down next month and be replaced by GM "lifer" and global product chief Mary Barra, a sign that the development of new vehicles will be the paramount focus of  ~Wall Street falls after record; Fed remains in focus NEW YORK Stocks slipped on Tuesday, a day after a record close on the S&P; 500, with traders looking ahead to next week's Federal Reserve meeting in the absence of market-moving economic data. ~US STOCKS-Wall St slightly lower, S&P; retreats from record close * Lululemon falls as retailer names new CEO, founder steps down ~BRIEF-GM CEO Akerson: Barra picked as his successor for her talent, not her gender DETROIT, Dec 10 General Motors Co CEO Dan Akerson on conference call with media:  * CEO Akerson says roughly two months ago family learned of his wife's cancer  * CEO Akerson says every board plans for succession  * CEO Akerson says mary barra "great choice" as his successor  * CEO Akerson says barra has vision where she wants to take GM  * CEO Akerson says thought GM had the talent within the company and didn't look ~US STOCKS-Wall St retreats from record S&P; 500 close * Lululemon falls as retailer names new CEO, founder steps down ~GM CEO Akerson to exit in January, Barra to take his place DETROIT, Dec 10 General Motors Co on Tuesday said Chief Executive Dan Akerson will step down next month and be replaced by Mary Barra, the company's global product development chief, marking the first time a major U.S. automaker has been led by a woman. ~US STOCKS-Wall St set for lower open after record close; GM in focus * Lululemon names new CEO, founder Chip Wilson to step down; shares up ~
GS,UPDATE 1-Trafigura says has no plans to sell warehousing unit * Traders have logistical reasons for owning warehouse firms ~Owners of debt collector Lindorff appoint banks for share sale-sources * Goldman Sachs, Morgan Stanley, SEB, Carnegie to lead IPO ~
JNJ,UPDATE 2-EU regulators fine J&J;, Novartis for generic drug deal BRUSSELS, Dec 10 European Union regulators have fined drugmakers Johnson & Johnson and Novartis  16.3 million euros ($22 million) for blocking the sale of a cheaper generic rival to their painkiller fentanyl. ~EU regulators fine J&J;, Novartis 16 mln euros for generic drug deal BRUSSELS, Dec 10 European Union antitrust regulators fined drugmakers Johnson & Johnson and Novartis a total of 16 million euros ($21.95 million) on Tuesday for blocking the sale of a generic painkiller in the Dutch market. ~
LLY,UPDATE 2-Merck moves Alzheimer's drug into big trials after safety review Dec 10 Merck & Co said it will begin two late-stage trials of its experimental Alzheimer's drug, one of the industry's best hopes for slowing the memory-robbing disease, after an independent monitoring board reviewed its safety and recommended that more patients be recruited for studies. ~
MA,MasterCard raises dividend by 83 pct, shares rise Dec 10 MasterCard Inc, the world's No.2 credit and debit card company, raised its quarterly dividend by 83 percent and announced a new $3.5 billion share buyback program, sending its shares up 3 percent in extended trading. ~
MCK,Investor Elliott urges McKesson to sweeten Celesio bid FRANKFURT Hedge fund Elliott International pressed U.S. drugs wholesale group McKesson  for a mark-up on its $8.3 billion offer for German peer Celesio , triggering a standoff with hundreds of millions of dollars at stake. ~UPDATE 1-Investor Elliott urges McKesson to sweeten Celesio bid FRANKFURT, Dec 10 Hedge fund Elliott International pressed U.S. drugs wholesale group McKesson  for a mark-up on its $8.3 billion offer for German peer Celesio, triggering a standoff with hundreds of millions of dollars at stake. ~Hedge fund Elliott wants McKesson to sweeten Celesio bid FRANKFURT, Dec 10 Hedge fund Elliott International is pushing U.S. drugs wholesale group McKesson  to hike its $8.3 billion offer for German peer Celesio . ~Hedge fund Elliott pushes McKesson to hike Celesio offer -source FRANKFURT, Dec 10 Hedge fund Elliott International is pushing U.S. drugs wholesale group McKesson  to hike its $8.3 billion offer for German peer Celesio , a source close to the investor said. ~
MRK,Merck moves Alzheimer's drug into big trial after safety review Dec 10 Merck & Co said it will advance its experimental Alzheimer's drug into late-stage trials among patients with mild to moderate disease, after an independent monitoring board reviewed its safety and recommended the trial continue to recruit patients. ~
MU.O,US STOCKS-S&P; 500 slips from record, Fed remains in focus * Indexes down: Dow 0.25 pct; S&P; 0.27 pct; Nasdaq 0.2 pct ~
MSFT.O,India court seeks value of Nokia factory seized in tax dispute Dec 10 An Indian court extended a hearing over local tax authorities' seizure of a Nokia factory by seeking information on the plant  value, adding to concerns whether the company can transfer the property to Microsoft as part of the sale of its mobile phone business. ~
MON,UPDATE 1-Monsanto deal with Novozymes aims to accelerate new crop products Dec 10 Monsanto Co, the world's largest seed company, said Tuesday that a deal with Danish company Novozymes to form a long-term research and development alliance should accelerate the release of microbial-based products designed to improve crop production. ~Novozymes and Monsanto form microbial alliance COPENHAGEN Denmark's Novozymes A/S  and U.S.-based Monsanto Co  have entered into a long-term alliance to boost research and commercialization of microbial products for agriculture, the Danish company said in a statement on Tuesday. ~Monsanto deal with Novozymes aims to accelerate new crop products Dec 10 Monsanto Co, the world's largest seed company, said Tuesday that a deal with Danish company Novozymes to form a long-term research and development alliance should accelerate the release of microbial-based products designed to improve crop production. ~UPDATE 1-Novozymes and Monsanto form microbial alliance * Two groups team up in microbial products for agriculture ~Novozymes and Monsanto form microbial alliance COPENHAGEN, Dec 10 Denmark's Novozymes  and U.S.-based Monsanto have entered into a long-term alliance to boost research and commercialisation of microbial solutions for agriculture, the Danish company said in a statement on Tuesday. ~RPT-BRIEF-Novozymes, Monsanto team up in bioagricultural solutions COPENHAGEN, Dec 10 Danish enzymes producer Novozymes said on Tuesday: ~BRIEF-Novozymes, Monsanto team up in bioagricultural solutions COPENHAGEN, Dec 10 Danish enzymes producer Novozymes said on Tuesday: ~
MS,Owners of debt collector Lindorff appoint banks for share sale-sources * Goldman Sachs, Morgan Stanley, SEB, Carnegie to lead IPO ~
OXY,Market Chatter- Corporate finance press digest Dec 10 The following corporate finance-related stories were reported by media: ~
SJP.L,Lloyds raises 680 mln stg from St James's Place sale LONDON, Dec 10 Lloyds Banking Group  said it raised 680 million pounds from the sale of its remaining 21 percent stake in wealth manager St James's Place, bolstering its capital to help meet tougher new rules. ~
URBN.O,BRIEF-Urban Outfitters shares up 4.3 pct in after-hours trading NEW YORK, Dec 10 Urban Outfitters Inc :  * Shares up 4.3 percent in after-hours trading ~
VZ,Vodafone sees Verizon deal finalized around early March NEW YORK, Dec 10 Vodafone Group Plc  expects to close the $130 billion sale of its 45 percent stake in Verizon Wireless to Verizon Communications and that shareholders will have received the proceeds of the deal by early March in line with the companies' target for a first quarter close. ~
WM,China waste firm Everbright Intl plans up to $484 mln share sale-IFR HONG KONG, Dec 10 Waste management and energy company China Everbright International Ltd is seeking to raise up to HK$3.75 billion ($484 million) by issuing new shares, IFR reported on Tuesday, citing sources. ~
